cetuximab,afatinib,pembrolizumab,adagrasib
mirati,boehringer ingelheim,eli lilly,merck
['colorectal', 'krystal-1', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'adagrasib', 'rectal', 'crcsm']
updated results from the krystal-1 study of adagrasib in advanced kras g12c mutated colorectal cancer #crcsm #colorectalcancer #esmo22 #oncology
News and views from the world of clinical oncology and hematology